Published in Blood Weekly, September 23rd, 1996
LEH is an experimental artificial oxygen-carrying resuscitative fluid that is being developed for use in patients with post-traumatic hypotension, noted Victoria Kwasiborski, Naval Research Laboratory, Washington, D.C., and colleagues (Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1996;24(4):abstract 373).
Liposomes are biodegradable capsules that allow oxygen diffusion while encapsulating the hemoglobin within an aqueous environment.
Numerous animal studies have demonstrated that liposomes with hemoglobin have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1996-09-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.